Corlopam (fenoldopam) is a small molecule pharmaceutical. Fenoldopam was first approved as Corlopam on 1997-09-23. It is used to treat heart failure, malignant hypertension, and renovascular hypertension in the USA. The pharmaceutical is active against D(1A) dopamine receptor. In addition, it is known to target D(4) dopamine receptor and D(1B) dopamine receptor.
|Indication||heart failure, malignant hypertension, renovascular hypertension|